Systemic Therapy Development in Von Hippel–Lindau Disease: An Outsized Contribution from an Orphan Disease

SIMPLE SUMMARY: This review highlights the development of systemic anti-neoplastic therapies for the treatment of patients with von Hippel–Lindau disease, culminating with the recent approval of the first systemic agent for this disease. ABSTRACT: Over the last several decades, an improved understan...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayan, Vivek, Jonasch, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658616/
https://www.ncbi.nlm.nih.gov/pubmed/36358730
http://dx.doi.org/10.3390/cancers14215313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658616/
https://www.ncbi.nlm.nih.gov/pubmed/36358730
http://dx.doi.org/10.3390/cancers14215313

Ejemplares similares